Stock A072020 CHOONG ANG VACCINE LABORATORY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Choong Ang Vaccine Laboratory Co., Ltd.

Equities

A072020

KR7072020001

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 13/05/2024 BST 		5-day change 1st Jan Change
10,850 KRW +0.28% Intraday chart for Choong Ang Vaccine Laboratory Co., Ltd. -0.18% -1.45%
05-10 Choong Ang Vaccine Laboratory Co., Ltd. announces an Equity Buyback for 100,000 shares. CI
05-10 Choong Ang Vaccine Laboratory Co., Ltd. authorizes a Buyback Plan. CI

Valuation

Fiscal Period: December 2020 2021 2022
Capitalization 1 171,312 147,880 107,346
Enterprise Value (EV) 1 158,806 138,302 101,903
P/E ratio 53.8 x 19.4 x 26.5 x
Yield - 0.67% 0.91%
Capitalization / Revenue 4.72 x 3.61 x 2.73 x
EV / Revenue 4.37 x 3.38 x 2.59 x
EV / EBITDA 18.9 x 14.5 x 9.86 x
EV / FCF - -30,704,404 x -35,300,925 x
FCF Yield - -0% -0%
Price to Book 1.94 x 1.57 x 1.12 x
Nbr of stocks (in thousands) 9,960 9,859 9,759
Reference price 2 17,200 15,000 11,000
Announcement Date 21/03/22 21/03/22 20/03/23
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022
Net sales 1 36,318 40,914 39,299
EBITDA 1 8,421 9,547 10,337
EBIT 1 4,031 4,541 4,283
Operating Margin 11.1% 11.1% 10.9%
Earnings before Tax (EBT) 1 3,313 6,401 4,807
Net income 1 3,164 7,602 4,044
Net margin 8.71% 18.58% 10.29%
EPS 2 320.0 772.0 414.8
Free Cash Flow - -4,504 -2,887
FCF margin - -11.01% -7.35%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - 100.0 100.0
Announcement Date 21/03/22 21/03/22 20/03/23
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022
Net Debt 1 - - -
Net Cash position 1 12,506 9,579 5,443
Leverage (Debt/EBITDA) - - -
Free Cash Flow - -4,504 -2,887
ROE (net income / shareholders' equity) - 8.42% 4.3%
ROA (Net income/ Total Assets) - 2.6% 2.35%
Assets 1 - 291,840 172,104
Book Value Per Share 2 8,880 9,528 9,859
Cash Flow per Share 2 1,246 1,162 812.0
Capex 1 15,404 14,311 7,104
Capex / Sales 42.42% 34.98% 18.08%
Announcement Date 21/03/22 21/03/22 20/03/23
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Veterinary Drugs

1st Jan change Capi.
CHOONG ANG VACCINE LABORATORY CO., LTD. Stock Choong Ang Vaccine Laboratory Co., Ltd.
-1.45% 76.8M
ZOETIS INC. Stock Zoetis Inc.
-12.14% 77.05B
BLUESTAR ADISSEO COMPANY Stock Bluestar Adisseo Company
+25.25% 3.73B
VIRBAC Stock Virbac
+1.95% 3.33B
VIMIAN GROUP AB Stock Vimian Group AB
+18.24% 1.69B
JINYU BIO-TECHNOLOGY CO., LTD. Stock Jinyu Bio-technology Co., Ltd.
-8.73% 1.52B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. Stock China Animal Husbandry Industry Co., Ltd.
-23.19% 1.3B
VETOQUINOL SA Stock Vetoquinol SA
-2.34% 1.27B
WUHAN KEQIAN BIOLOGY CO.,LTD Stock Wuhan Keqian Biology Co.,Ltd
-12.66% 1.18B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD. Stock Tianjin Ringpu Bio-Technology Co.,Ltd.
+0.24% 1.09B
Veterinary Drugs
  1. Stock Market
  2. Equities
  3. A072020 Stock
  4. Financials Choong Ang Vaccine Laboratory Co., Ltd.